SWOG 1400 / Lung-MAP

The ECOG-ACRIN Cancer Research Group is participating in the Lung Cancer Master Protocol (Lung-MAP), a unique collaborative trial to establish a National Clinical Trials Network mechanism for genomically screening large but homogeneous cancer populations and matching the genomic profile of a patient’s tumor with a biomarker-driven substudy. Substudies compare new targeted therapy or targeted therapy combinations to standard care therapy.

Additional Information: lung-map.org